Related Experiment Video

Updated: May 28, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells

Jin Lu Tong1, Chen Peng Zhang, Fang Nie

  • 1Division of Gastroenterology and Hepatology, Shanghai Jiao-Tong University School of Medicine, Renji Hospital, Shanghai, China.

FEBS Letters
|November 1, 2011
PubMed

Insights

Overexpressed miR-506 in colon cancer cells drives chemotherapy resistance by inhibiting PPARα. This finding offers a potential strategy to overcome drug resistance in colon cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Chemotherapy resistance is a significant challenge in colon cancer treatment.
  • Identifying molecular mechanisms underlying drug resistance is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the role of microRNAs (miRNAs) in conferring resistance to chemotherapy in colon cancer.
  • To identify specific miRNAs and their targets involved in drug resistance.

Main Methods:

  • Differential miRNA expression analysis between drug-sensitive and drug-resistant colon cancer cell lines.
  • Validation of miRNA overexpression using quantitative real-time PCR.
  • Luciferase reporter assays to confirm miRNA target interactions.
  • Assessment of cell viability and anti-tumor effects under varying PPARα expression levels.

Main Results:

  • 77 differentially expressed miRNAs were identified, with miR-506 found to be overexpressed in drug-resistant cells.
  • PPARα was confirmed as a direct target of miR-506.
  • Loss of PPARα expression was associated with resistance to HCPT's anti-tumor effects.
  • Overexpression of miR-506 in resistant cells inhibited PPARα and conferred resistance to HCPT.

Conclusions:

  • miR-506 overexpression contributes to HCPT resistance in colon cancer by targeting and inhibiting PPARα.
  • Targeting miR-506 or restoring PPARα expression may represent a therapeutic approach to overcome chemotherapy resistance in colon cancer.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...